User talk:Z3332250: Difference between revisions
From Embryology
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
**Idebenone | **Idebenone | ||
**Coenzyme Q10 | **Coenzyme Q10 | ||
Q10 an electron carrier of reduction of oxidative stress with the combination of vitamin E, combination of Q10 and vitamin E displayed a positive effect<ref name="PMID:19049556"><pubmed>19049556</pubmed></ref>. Where Q10 and vitamin E conveyed the cardiac and skeletal improvement with the betterment of the mitochondrial synthesis<ref name="PMID:15824263"><pubmed>15824263</pubmed></ref>. | |||
Revision as of 19:37, 7 September 2011
Articles to read:
"""Carido"""
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1728941/?tool=pmcentrez
- http://www.ncbi.nlm.nih.gov/pubmed/2940284
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1728941/pdf/v081p00141.pdf
- http://www.ncbi.nlm.nih.gov/pubmed/2944367
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1894724/?tool=pmcentrez
[1]
Treatment
friedreich Ataxia (FA) a progressive neurological congenital disorder[2], wtih no treatment identified only possible pharmaceutics which can reduce the progression of FA however not significantly. Whereas significant treatment poties of FA or reduction in progression are the following:
- Iron-chelation
- deferoxamine
- Antioxidants:
- Idebenone
- Coenzyme Q10
Q10 an electron carrier of reduction of oxidative stress with the combination of vitamin E, combination of Q10 and vitamin E displayed a positive effect[3]. Where Q10 and vitamin E conveyed the cardiac and skeletal improvement with the betterment of the mitochondrial synthesis[4].
